Bank of New York Mellon »

Merrimack Pharma shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Merrimack Pharma (MACK) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Merrimack Pharma

Tip: Access up to 7 years of quarterly data

All positions including Merrimack Pharma held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merrimack Pharma by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 95k 14.77
2023-12-31 $1.3M 100k 13.41
2023-09-30 $1.2M 100k 12.33
2023-06-30 $1.2M 100k 12.30
2023-03-31 $920k 75k 12.29
2022-12-31 $858k 75k 11.46
2022-09-30 $152k 41k 3.72
2022-06-30 $244k 41k 5.95
2022-03-31 $259k 41k 6.33
2021-12-31 $161k 41k 3.92
2021-09-30 $198k 41k 4.83
2021-06-30 $263k 41k 6.40
2021-03-31 $266k 42k 6.29
2020-12-31 $121k 18k 6.91
2020-09-30 $70k 18k 4.00
2020-06-30 $0 18k 0.00
2020-03-31 $38k 18k 2.17
2019-12-31 $56k 18k 3.18
2019-09-30 $79k 18k 4.48
2019-06-30 $107k 18k 6.07
2019-03-31 $123k 18k 6.98
2018-12-31 $70k 18k 3.83
2018-06-30 $211k 43k 4.90
2018-03-31 $637k 79k 8.02
2017-12-31 $823k 80k 10.25